# Biorithm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biorithm

- Industry: Healthcare IT
- Headquarters: Singapore, Singapore
- Website: http://www.bio-rithm.com
- Total disclosed funding: $4.2M
- Latest round: Series A (Dec 18, 2023)
- Investors on record: 5

## About

Founded in 2016 and based in Singapore, Biorithm is a Nanyang Technological University-based medical technology start-up that offers a remote monitoring platform to increase access to healthcare for pregnant women. In February 2016, Biorithm raised funding from AIA Konica Minolta Digital Health Accelerator. Amrish Nair (CEO), David Foo, and Pina Marziliano are the co-founders of the company.

The company offers femom lite, an obstetrics remote monitoring platform that is designed to provide risk-based home care for prenatal and postnatal patients. The firm's femom fetal monitor offers clinical benefits of fetal ECG monitoring, non-invasive recording of the fetal heart rate, mother heart rate, and uterine contraction.

## Funding rounds

- Series A, Dec 18, 2023, $3.5M — SEEDS Capital, Adaptive Capital Partners
- Series A, Sep 1, 2020, $0.7M — SEEDS Capital, NTUitive, Pureland Global Venture, Yongfah Capital Pte. Ltd.

## Investors

- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A
- NTUitive (https://capitalatlas.ai/funds/ntuitive) — Series A
- Pureland Global Venture (https://capitalatlas.ai/funds/pureland-global-venture) — Series A
- Yongfah Capital Pte. Ltd. — Series A
- Adaptive Capital Partners (https://capitalatlas.ai/funds/adaptive-capital-partners) — Series A